15. Bonab MM, Sahraian MA, Aghsaie A, et al. Autologous mesenchymal
stem cell therapy in progressive multiple sclerosis: an open label study. Curr
Stem Cell Res Ther. 2012; 7(6): 407-414.
16. Connick P, Kolappan M, Crawley C, et al. Autologous mesenchymal
stem cells for the treatment of secondary progressive multiple sclerosis: an open-
label phase 2a proof-of-concept study. Lancet Neurol. 2012; 11(2): 150-156. doi:
10.1016/S1474-4422(11)70305-2.
17. Yamout B, Hourani R, Salti H, et al. Bone marrow mesenchymal stem
cell transplantation in patients with multiple sclerosis: a pilot study. J
Neuroimmunol. 2010; 227(1-2): 185-189. doi: 10.1016/j.jneuroim.2010.07.013.
18. Northwestern University; Richard Burt, MD. Stem cell therapy for
patients with multiple sclerosis failing alternate approved therapy- a randomized
study. In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of
Medicine
(US).
2000-
[cited
2016
July].
Available
from:
https://clinicaltrials.gov/ct2/show/NCT00273364
NLM
Identifier:
NCT00273364.
19. Translational Biosciences. Feasibility study of human umbilical cord
tissue-derived mesenchymal stem cells in patients with multiple sclerosis. In:
ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US).
2000-
[cited
2016
July].
Available
from:
https://clinicaltrials.gov/ct2/show/NCT02034188
NLM
Identifier:
NCT02034188.
20. University of Louisville. Allogeneic stem cell transplantation for the
treatment of multiple sclerosis. In: ClinicalTrials.gov [Internet]. Bethesda (MD):
National Library of Medicine (US). 2000- [cited 2016 July]. Available from:
https://clinicaltrials.gov/ct2/show/NCT00497952
NLM
Identifier:
NCT00497952.
21. Karolinska Institutet; Ellen Iacobaeus. Mesenchymal stem cells for
multiple sclerosis. In: ClinicalTrials.gov [Internet]. Bethesda (MD): National
Library of Medicine (US). 2000- [cited 2016 July]. Available from:
https://clinicaltrials.gov/ct2/show/NCT01730547
NLM
Identifier:
NCT01730547.
